Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cell Cycle (Georgetown, Tex.)|December 18, 2009
Tumor suppression by ARF: gatekeeper and caretakerCarmen Dominguez-Brauer, Patrick M Brauer, Yi-Ju Chen, et al.
EMBO Reports|August 1, 2009
ARF stimulates XPC to trigger nucleotide excision repair by regulating the repressor complex of E2F4Carmen Dominguez-Brauer, Yi-Ju Chen, Patrick M Brauer, et al.
Molecular and Cellular Biology|March 31, 2010
DDB2, an essential mediator of premature senescenceNilotpal Roy, Tanya Stoyanova, Carmen Dominguez-Brauer, et al.
Molecular Cell|November 23, 2015
Targeting Mitosis in Cancer: Emerging StrategiesCarmen Dominguez-Brauer, Kelsie L Thu, Jacqueline M Mason, et al.
Plos One|April 12, 2011
The alternative splice variant of protein tyrosine kinase 6 negatively regulates growth and enhances PTK6-mediated inhibition of β-cateninPatrick M Brauer, Yu Zheng, Mark D Evans, et al.
Scientific Reports|April 13, 2016
Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunitySong Hui Chng, Parag Kundu, Carmen Dominguez-Brauer, et al.
Cancer Research|December 3, 2008
The ARF tumor suppressor can promote the progression of some tumorsOlivier Humbey, Julia Pimkina, Jack T Zilfou, et al.
The Journal of Biological Chemistry|September 10, 2009
A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1Yi-Ju Chen, Carmen Dominguez-Brauer, Zebin Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 2017
E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signalingCarmen Dominguez-Brauer, Rahima Khatun, Andrew J Elia, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 21, 2016
Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered miceZhenyue Hao, Rob A Cairns, Satoshi Inoue, et al.
Pageof 2